{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:43:34Z","timestamp":1789505014664,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.imlet.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T20:31:56Z","timestamp":1390077116000},"page":"236-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30+T cells"],"prefix":"10.1016","volume":"161","author":[{"given":"Elisa","family":"Tinazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Patuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Beri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2014.01.007_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signalling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.imlet.2014.01.007_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and therapy","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.01.007_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3899\/jrheum.080288","article-title":"CD153 in rheumatoid arthritis: detection of a soluble form in serum and synovial fluid and expression by mast cells in the rheumatic synovium","volume":"36","author":"Carvalho","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.165.2.786","article-title":"Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+IgM+ B cells","volume":"165","author":"Cerruti","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/84254","article-title":"Dysregulation of CD30+ T cells by leukaemia impairs isotype switching in normal B cells","volume":"2","author":"Cerruti","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0035","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1000024","article-title":"CD30 ligand\/CD30 plays a critical role in Th17 differentiation in mice","volume":"185","author":"Sun","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0040","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.157.8.3635","article-title":"Reverse signalling via CD30 ligand","volume":"157","author":"Wiley","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via Bcl-2-sensitive pathway","volume":"163","author":"Chiarle","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0050","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.4049\/jimmunol.160.5.2180","article-title":"Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines","volume":"160","author":"Gilfillan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1034\/j.1398-9995.2001.00137.x","article-title":"The role of CD30 in atopic disease","volume":"56","author":"Bengtsson","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.imlet.2014.01.007_bib0060","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaci.2006.07.014","article-title":"Direct evidence for a critical role of CD30 in the development of allergic asthma","volume":"118","author":"Polte","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1471-4906(00)01829-9","article-title":"Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases","volume":"22","author":"Gerli","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20020319","article-title":"Inhibition of type I cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus","volume":"196","author":"Saraiva","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.01.007_bib0075","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.4049\/jimmunol.181.9.6316","article-title":"A novel role of CD30L\/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection","volume":"181","author":"Tang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0080","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/IAI.00887-13","article-title":"CD30 is required for activation of a unique subset of interleukin-17A-producing gd T cells in innate immunity against Mycobacterium bovis bacillus Calmette-Guerin infection","volume":"10","author":"Guo","year":"2013","journal-title":"IAI"},{"key":"10.1016\/j.imlet.2014.01.007_bib0085","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ni853","article-title":"Dominant transplantation tolerance impairs CD8+ T cell function but not expansion","volume":"3","author":"Lin","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI19727","article-title":"CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism","volume":"113","author":"Dai","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2014.01.007_bib0095","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.174.7.3891","article-title":"Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T-cell memory","volume":"174","author":"Gaspal","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0100","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood-2006-07-038455","article-title":"Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease","volume":"109","author":"Zeiser","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.01.007_bib0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/978-0-387-89520-8_12","article-title":"Targeting CD30\/CD30L in oncology and autoimmune and inflammatory diseases","volume":"647","author":"Oflazoglu","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.1995.tb03851.x","article-title":"High levels of the soluble form of CD30 molecule in rheumatoid arthritis (AR) are expression of CD30+ T cell involvement in the inflamed joints","volume":"102","author":"Gerli","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0115","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.164.8.4399","article-title":"CD30-positive T cells in rheumatoid arthritis synovitis: mechanisms of recruitment and functional role","volume":"164","author":"Gerli","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002281-200005000-00004","article-title":"Are T cells in rheumatoid synovium aggressors or bystanders?","volume":"12","author":"Miossec","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3083.1999.00581.x","article-title":"Changes in Th1\/Th2 phenotype of memory T-cell clones from rheumatoid synovium","volume":"50","author":"Aarvak","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0130","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.4049\/jimmunol.158.5.2090","article-title":"Reciprocal regulation of CD30 expression in CD4+ T cells by IL-4 and IFN-\u03b3","volume":"158","author":"Nakamura","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0966-3274(03)00014-5","article-title":"CD30 antigen: not a physiological marker for Th2 cells but an important costimulator molecule in the regulation of the balance between Th1\/Th2 response","volume":"12","author":"Pellegrini","year":"2003","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/38.12.1282","article-title":"Soluble CD30 in rheumatoid arthritis as predictor of good response to second line therapy","volume":"38","author":"Gerli","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2014.01.007_bib0145","first-page":"14","article-title":"Anti-TNFa response in rheumatoid arthritis patients is associated with an increase in serum soluble CD30 levels","volume":"35","author":"Gerli","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2014.01.007_bib0150","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid Arthritis Classification criteria. An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.01.007_bib0155","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","article-title":"The 2010 American college of Rheumatology\/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis. Phase 2 methodological report","volume":"62","author":"Neogi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.01.007_bib0160","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human CMV late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2014.01.007_bib0165","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V93.5.1715","article-title":"Heparin-binding epidermal growth factor-like growth factor\/diphtheria toxin receptor expression by acute myeloid leukemia cells","volume":"93","author":"Vinante","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.01.007_bib0170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V99.1.52","article-title":"CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540","volume":"99","author":"Vinante","year":"2002","journal-title":"Blood"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781400011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781400011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T22:38:53Z","timestamp":1688942333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781400011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S016524781400011X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2014.01.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30+T cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}